Sector: MedicalSCIELE PHARMA INC (NASDAQ: SCRX)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 143 |
Technical : | 149 |
Performance : | 47 |
Overall: | 85 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 152 |
Technical : | 121 |
Performance : | 46 |
Overall: | 70 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 144 |
Technical : | 178 |
Performance : | 54 |
Overall: | 101 |
Number of Stocks: | 306 |
Headlines
- Few Stocks Trading Higher With Large Volumes
Oct 08, 2008 12:35 PM | DMND, LDK, PSPT, SCRX
- Weekly Mergers and Acquisitions Report - Sep 15 2008 10:57AM
Sep 15, 2008 10:34 AM | BG, BHP, BMY, BRL, BUD, CKXE
- Initial Analysis on Sciele Pharma, Inc. (SCRX) - Shionogi Merger
Sep 05, 2008 05:36 PM | SCRX
- Analyst Comments: ProLogis, Banco Bradesco, Sciele Pharma, Motorola, Eastman Chemical, Equifax, Astec Industries, Intersil
Sep 04, 2008 08:38 AM | ASTE, BBD, EFX, EMN, ISIL, MOT
- After Gustav & Labor Day
Sep 02, 2008 10:31 AM | AAUK, ACGY, AMR, ATW, BBL, BDSI
- Japan’s Shionogi To Acquire Sciele Pharma for $1.42 Billion
Sep 02, 2008 12:40 AM | SCRX
- Analyst Comments: BT Group, FEMSA, Sciele Pharma, Newmont Mining, Allot Communications, Orthopedic Group, JA Solar
May 01, 2008 02:56 PM | ALLT, BT, FMX, GME, HGR, JASO
- Analyst Comments: Rent-A-Center, Sciele Pharma, Western Digital, Immucor, Gafisa S.A., Biogen Idec
Feb 07, 2008 01:03 AM | AZN, BIIB, BLUD, GFA, PFE, RCII
- Bear Market Mode
Jan 16, 2008 10:12 AM | AAPL, ABK, ADCT, AKNS, AMAT, AMED
- Medspas of America Signs Private Label Packaging Agreement With Essential Wholesale and Sciele Expects to Launch Six Products in 2008; Reaffirms Revenue and EPS Guidance for Full-Years 2007 and 2008
Jan 10, 2008 02:29 PM | ARXT, BSX, SCRX
- Shionogi Completes Acquisition of Sciele
Oct 09, 2008 05:03 PM | SCRX
- Shionogi and Sciele Announce Completion of Subsequent Offering Period
Oct 09, 2008 07:31 AM | SCRX
- Shionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent Offering
Oct 06, 2008 06:31 AM | SCRX
- Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation
Sep 30, 2008 03:02 PM | SCRX
- Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. Indices - Sep 25 2008 7:47PM
Sep 25, 2008 07:39 PM | CY, HPY, HRH, MHP, OII, SCRX
- Shionogi and Sciele Announce Receipt of United States Antitrust Clearance
Sep 19, 2008 06:01 AM | SCRX
- Sciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe Drooling
Sep 16, 2008 09:51 AM | SCRX
- Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel for ADHD
Sep 10, 2008 01:51 PM | SCRX
- Sciele Pharma, Inc. Gives Notice of Anticipated Effective Date of Make-Whole Fundamental Change to Holders of Convertible Notes
Sep 08, 2008 12:12 PM | SCRX
- Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.
Sep 01, 2008 05:02 AM | SCRX
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
SCRX
|
Compare to S&P
|
| YTD |
51.39 %
|
101.19 %
|
| 4 Weeks |
0.42 %
|
24.85 %
|
| 12 Weeks |
56.36 %
|
92.87 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 31.43 %
|
|
EPS Growth in Last Year: 17.95 %
|
|
Sales Growth in Last Quarter: 2.79 %
|
|
Sales Growth in Last Quarter: 7.92 %
|
|
